IMC Chicago’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Sell
77,904
-46,254
-37% -$109K ﹤0.01% 5162
2025
Q4
$336K Buy
124,158
+46,791
+60% +$154K ﹤0.01% 3731
2025
Q3
$327K Sell
77,367
-1,249
-2% -$5.49K ﹤0.01% 3378
2025
Q2
$392K Buy
78,616
+13,330
+20% +$57.9K ﹤0.01% 2990
2025
Q1
$288K Sell
65,286
-29
-0% -$136 ﹤0.01% 2944
2024
Q4
$304K Buy
+65,315
New +$359K ﹤0.01% 2976

Other funds holding GDRX

IMC Chicago's GDRX Position: Q1 2026 in Review

IMC Chicago reduced its GoodRx Holdings (GDRX) stake by 37% in Q1 2026, selling an estimated $109K and leaving 77,904 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #5162.

IMC Chicago first reported a position in GDRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $392K in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • IMC Chicago held 77,904 shares of GoodRx Holdings worth $153K as of Q1 2026.
  • IMC Chicago sold 46,254 GoodRx Holdings shares in Q1 2026, an estimated $109K.
  • GoodRx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5162 holding.
  • IMC Chicago first reported a position in GoodRx Holdings in Q4 2024 and has held it in 6 quarters since.
  • IMC Chicago's GoodRx Holdings position peaked at $392K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.